GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Colinz Laboratories Ltd (BOM:531210) » Definitions » ROE % Adjusted to Book Value

Colinz Laboratories (BOM:531210) ROE % Adjusted to Book Value : 5.74% (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Colinz Laboratories ROE % Adjusted to Book Value?

Colinz Laboratories's ROE % for the quarter that ended in Mar. 2024 was 6.08%. Colinz Laboratories's PB Ratio for the quarter that ended in Mar. 2024 was 1.06. Colinz Laboratories's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 5.74%.


Colinz Laboratories ROE % Adjusted to Book Value Historical Data

The historical data trend for Colinz Laboratories's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Colinz Laboratories ROE % Adjusted to Book Value Chart

Colinz Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.18 6.13 3.24 5.35 5.38

Colinz Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 5.82 - - 5.74

Competitive Comparison of Colinz Laboratories's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Colinz Laboratories's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Colinz Laboratories's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Colinz Laboratories's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Colinz Laboratories's ROE % Adjusted to Book Value falls into.



Colinz Laboratories ROE % Adjusted to Book Value Calculation

Colinz Laboratories's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=5.70% / 1.06
=5.38%

Colinz Laboratories's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=6.08% / 1.06
=5.74%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Colinz Laboratories ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Colinz Laboratories's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Colinz Laboratories (BOM:531210) Business Description

Traded in Other Exchanges
N/A
Address
Mulund Goregaon Link Road, A-101 Pratik Industrial Estate, Next to Fortis Hospital, Bhandup (West), Mumbai, MH, IND, 400078
Colinz Laboratories Ltd is an India based company engaged in manufacturing of pharmaceutical formulations. It offers formulations in the products category of ayurvedic, allopathy, and nutraceuticals. The company manufactures pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams, and others. It also has certain specialized products for gynecology, cardiology, gastroenterology, and others. The group derives revenue from the sale of its products in India.

Colinz Laboratories (BOM:531210) Headlines

No Headlines